Drug Firm From Japan Buys Maker of Lunesta

Thursday, September 3, 2009 - 23:00 in Mathematics & Economics

The American drug maker Sepracor accepted an offer of $2.6 billion from Dainippon, which wants more products and overseas sales.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net